Graft-versus-host disease (GVHD) continues to be a major complication following allogeneic
hematopoietic cell transplantation (allo-HCT) with high morbidity and mortality …

Despite the use of up-to-date immunosuppressive agents, graft rejection episodes are quite
common and pose a serious threat to thousands of solid organ recipients. Continuous use of …

Extracorporeal photopheresis (ECP) is broadly used in adults with cutaneous T-cell
lymphoma, acute or chronic graft-versus-host disease (GVHD), rejection of solid organ …

Currently, more than 1080 peer-reviewed papers are displayed on PubMed when initiating a
search for therapeutic indications and mechanisms of action of extracorporeal …

Extracorporeal photopheresis (ECP) is an immunomodulation procedure that may be used
as an adjunct therapy in patients with cutaneous T cell leukemia/lymphoma, graftversus-host …

Graft-versus-host disease (GVHD) is a major complication of allogeneic bone marrow
transplantation. Extracorporeal photochemotherapy (ECP) has been introduced as an …

Background: Pro‐inflammatory cytokines are actively involved in graft‐versus host‐disease
(GvHD) aetiology. Treatment of GvHD, using extracorporeal photopheresis (ECP), has …

Extracorporeal photochemotherapy (ECP) has been progressively introduced into the
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …

Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …

Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …